Literature DB >> 7631347

Protective effect of cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion.

H Wakita1, H Tomimoto, I Akiguchi, J Kimura.   

Abstract

BACKGROUND AND
PURPOSE: Activation of glial cells and rarefaction of the white matter have been reported in rat brain after bilateral permanent occlusion of the common carotid arteries. Using this model, we investigated the effects of the immunosuppressant cyclosporin A on the activation of glial cells and the white matter rarefaction.
METHODS: Both common carotid arteries were ligated bilaterally in 40 male Wistar rats. Twenty-two of these rats received an intraperitoneal injection of cyclosporin A, and the remaining 18 received a vehicle-solution injection. Microglia/macrophages were investigated with immunohistochemistry for the major histocompatibility complex class I and II antigens as well as for leukocyte common antigen. Astroglia were examined with glial fibrillary acidic protein as a marker. Activation of glial cells and white matter rarefaction were then investigated from 7 to 30 days after the ligation.
RESULTS: In vehicle-treated animals, there was a persistent and extensive activation of both microglia/macrophages and astroglia in the white matter, including the optic nerve, optic tract, corpus callosum, internal capsule, and traversing fiber bundles of the caudoputamen. In cyclosporin A-treated rats, the number of activated microglia/macrophages was significantly reduced (P < .01) to approximately one fifth of that in vehicle-treated animals. Similarly, rarefaction of the white matter was much less intense in cyclosporin A-treated rats (P < .01).
CONCLUSIONS: Cyclosporin A suppressed both glial activation and white matter changes after chronic cerebral hypoperfusion. These results suggest that immunologic reaction may play a role in the pathogenesis of the white matter changes and that the present model may be useful in investigating the pathophysiology of white matter changes induced by chronic cerebral hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631347     DOI: 10.1161/01.str.26.8.1415

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

Review 1.  Rodent Models of Vascular Cognitive Impairment.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey Thompson; Gary A Rosenberg
Journal:  Transl Stroke Res       Date:  2016-08-08       Impact factor: 6.829

2.  Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

Authors:  K J Becker; R M McCarron; C Ruetzler; O Laban; E Sternberg; K C Flanders; J M Hallenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  Chronic cerebral hypoperfusion induces striatal alterations due to the transient increase of NO production and the depression of glutathione content.

Authors:  Ken-Ichi Tanaka; Naoko Wada-Tanaka; Ikuko Miyazaki; Masahiko Nomura; Norio Ogawa
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

Review 4.  From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.

Authors:  Yang Zhao; Cheng-Xin Gong
Journal:  Cell Mol Neurobiol       Date:  2014-10-29       Impact factor: 5.046

Review 5.  Brain white matter lesions and postoperative cognitive dysfunction: a review.

Authors:  Shinichi Nakao; Tomohisa Yamamoto; Seishi Kimura; Takashi Mino; Tatsushige Iwamoto
Journal:  J Anesth       Date:  2019-02-20       Impact factor: 2.078

6.  Chronic bilateral common carotid artery occlusion: a model for ocular ischemic syndrome in the rat.

Authors:  Daniel Lavinsky; Nice Sarmento Arterni; Matilde Achaval; Carlos Alexandre Netto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

7.  Estradiol Protects White Matter of Male C57BL6J Mice against Experimental Chronic Cerebral Hypoperfusion.

Authors:  Reymundo Dominguez; Madison Zitting; Qinghai Liu; Arati Patel; Robin Babadjouni; Drew M Hodis; Robert H Chow; William J Mack
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-03-27       Impact factor: 2.136

8.  Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen-glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model.

Authors:  Xiaohan Yang; Tiezheng Zheng; Hao Hong; Nan Cai; Xiaofeng Zhou; Changkai Sun; Liying Wu; Shuhong Liu; Yongqi Zhao; Lingling Zhu; Ming Fan; Xuezhong Zhou; Fengxie Jin
Journal:  Front Med       Date:  2017-10-02       Impact factor: 4.592

9.  Mucosal tolerization to E-selectin protects against memory dysfunction and white matter damage in a vascular cognitive impairment model.

Authors:  Hideaki Wakita; Christl Ruetzler; Kachikwu O Illoh; Yong Chen; Asako Takanohashi; Maria Spatz; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2007-07-18       Impact factor: 6.200

Review 10.  Role of microglia in ischemic focal stroke and recovery: focus on Toll-like receptors.

Authors:  Jenni E Anttila; Keith W Whitaker; Emily S Wires; Brandon K Harvey; Mikko Airavaara
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-07-04       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.